CD44 and hepatocellular carcinoma: As shown in Fig. 5e, cell viability was significantly higher in the presence of purmorphamine, suggesting that activation of Hedgehog signaling significantly decreased the inhibitory effects of the combination of sorafenib and GANT61 in CD44-positive HCC cell lines.